Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Dupilumab helps children with alopecia areata regrow hair safely.

Baricitinib is the most effective treatment for alopecia areata.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.